regn14256
Showing 1 - 1 of 1
SARS-CoV-2 Trial in United States (REGN14256, imdevimab, casirivimab + imdevimab)
Completed
- SARS-CoV-2
- REGN14256
- +3 more
-
La Mesa, California
- +27 more
Jul 5, 2022